4//SEC Filing
LA JOLLA PHARMACEUTICAL CO 4
Accession 0001209191-05-027443
CIK 0000920465operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:17 PM ET
Size
9.5 KB
Accession
0001209191-05-027443
Insider Transaction Report
Form 4
JENN PAUL
VP of Product Development
Transactions
- Award
Stock Option (right to buy)
2005-05-19$0.43/sh+27,080$11,644→ 489,474 totalExercise: $0.00Exp: 2015-05-19→ Common Stock (27,080 underlying)
Holdings
- 3,302
Common Stock
Footnotes (1)
- [F1]The stock options vest and become exercisable monthly over the next three years. In the event employee is terminated without cause or there is a change in control of the Company and employee's employment is terminated in connection with such change in control, the options automatically vest as of the date of employee's termination and remain exercisable for a period of one year following the date of termination.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000920465
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 5:17 PM ET
- Size
- 9.5 KB